STAT3 and hepatocellular carcinoma: Similarly, the intracellular lncRNA HClnc1 interacts with PKM2 to prevent its degradation, reinforcing aerobic glycolysis and activating PKM2-STAT3 signaling, which promotes angiogenesis, proliferation, chemoresistance, and anti-apoptotic mechanisms in HCC (50).